3D Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	444.32	666.47	696.74	774.31	414.26
Short-Term Investments	227.15	120.78	136.68	-	-
Trading Asset Securities	169.52	209.33	108.6	50.18	-
Cash & Short-Term Investments	840.98	996.58	942.03	824.48	414.26
Cash Growth	-15.61%	5.79%	14.26%	99.02%	-
Accounts Receivable	47.86	5.46	78.04	65	0.2
Other Receivables	75.54	79.54	76.63	7.29	10.4
Receivables	127.09	85	155.91	72.29	10.6
Inventory	4.06	4.61	1.2	0.01	-
Restricted Cash	-	-	-	0.07	-
Other Current Assets	15.62	8.97	43.93	22.37	36.9
Total Current Assets	987.75	1,095	1,143	919.23	461.76
Property, Plant & Equipment	147.73	193.25	177.84	118.54	26.8
Long-Term Investments	23.34	70.59	-	-	-
Other Intangible Assets	0.63	0.73	0.83	0.93	-
Other Long-Term Assets	56.82	11.89	6.02	17.18	7.66
Total Assets	1,216	1,429	1,332	1,060	496.22
Accounts Payable	51.13	71.9	15.88	3.74	2.42
Accrued Expenses	164.3	124.35	183.83	111.18	81.54
Short-Term Debt	195.59	174.37	103.99	-	3.52
Current Portion of Long-Term Debt	9	27	-	3,094	215.24
Current Portion of Leases	8.27	23.23	11.31	12.75	3.79
Current Income Taxes Payable	1.8	1.91	-	1.43	0.64
Current Unearned Revenue	-	24.54	-	-	-
Other Current Liabilities	57.69	53.08	61.24	24.98	7.86
Total Current Liabilities	487.79	500.37	376.25	3,248	315.01
Long-Term Debt	16.5	29.24	27	38.82	1,430
Long-Term Leases	8.25	28.58	33.4	45.99	13.06
Long-Term Unearned Revenue	-	-	-	-	7.58
Total Liabilities	512.54	558.2	436.65	3,333	1,766
Common Stock	0.23	0.23	0.22	0.06	0.04
Additional Paid-In Capital	4,785	4,785	4,228	134.66	-
Retained Earnings	-4,343	-4,161	-3,636	-2,612	-1,270
Treasury Stock	-0.17	-0.01	-0.03	-0.03	-
Comprehensive Income & Other	343.22	311.97	350.98	239.02	-
Total Common Equity	785.06	936.74	943	-2,238	-1,270
Minority Interest	-81.35	-66.05	-47.59	-34.55	-
Shareholders' Equity	703.71	870.69	895.41	-2,273	-1,270
Total Liabilities & Equity	1,216	1,429	1,332	1,060	496.22
Total Debt	237.62	282.43	175.7	3,192	1,666
Net Cash (Debt)	603.36	714.15	766.33	-2,367	-1,252
Net Cash Growth	-15.51%	-6.81%	-	-	-
Net Cash Per Share	2.46	3.13	16.85	-60.61	-27.45
Filing Date Shares Outstanding	244.97	245.07	224.2	36.45	45.6
Total Common Shares Outstanding	244.97	245.07	224.2	36.45	45.6
Working Capital	499.96	594.78	766.81	-2,329	146.75
Book Value Per Share	3.20	3.82	4.21	-61.40	-27.85
Tangible Book Value	784.44	936.01	942.17	-2,239	-1,270
Tangible Book Value Per Share	3.20	3.82	4.20	-61.43	-27.85
Machinery	9.58	8.28	8.06	7.06	3.41
Construction In Progress	112.02	112.02	99.87	28.16	-
Leasehold Improvements	31.16	35.09	33.16	23.43	10.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.